MPPE1 and neoplasm: Based on the knowledge discussed in the previous sections, we propose a putative model of the mechanisms through which cDC1 promote the rejection of syngeneic tumor grafts in preclinical mouse models (Table 2) and may physiologically contribute to cancer immunosurveillance (Figure 2).